Mangoceuticals, Inc.
MGRX
$1.73
$0.074.22%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 168.10K | 109.30K | 105.20K | 133.40K | 163.20K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 168.10K | 109.30K | 105.20K | 133.40K | 163.20K |
Cost of Revenue | 78.20K | 47.20K | 25.10K | 50.70K | 93.40K |
Gross Profit | 89.90K | 62.10K | 80.10K | 82.70K | 69.80K |
SG&A Expenses | 5.25M | 3.50M | 1.74M | 1.59M | 2.20M |
Depreciation & Amortization | -- | -- | 721.50K | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.33M | 3.54M | 2.49M | 1.64M | 2.29M |
Operating Income | -5.16M | -3.43M | -2.38M | -1.50M | -2.13M |
Income Before Tax | -5.42M | -4.84M | -1.95M | -2.00M | -2.39M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -5.42M | -4.84M | -1.95M | -2.00M | -2.39M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 0.00 | 100.00 | 200.00 | 500.00 | 300.00 |
Net Income | -5.42M | -4.84M | -1.95M | -2.00M | -2.39M |
EBIT | -5.16M | -3.43M | -2.38M | -1.50M | -2.13M |
EBITDA | -4.33M | -3.02M | -1.66M | -1.50M | -2.10M |
EPS Basic | -0.54 | -1.05 | -1.08 | -0.99 | -1.37 |
Normalized Basic EPS | -0.33 | -0.66 | -0.46 | -0.62 | -0.86 |
EPS Diluted | -0.54 | -1.05 | -1.08 | -0.99 | -1.37 |
Normalized Diluted EPS | -0.33 | -0.66 | -0.46 | -0.62 | -0.86 |
Average Basic Shares Outstanding | 9.98M | 4.59M | 2.62M | 2.01M | 1.74M |
Average Diluted Shares Outstanding | 9.98M | 4.59M | 2.62M | 2.01M | 1.74M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |